. Earth Science News .
EPIDEMICS
New approach to defeating flu shows promise

GM-SCF boosts innate immunity to make it immediately effective against the virus, and its protective effect has not been shown to be strain dependant so far. Alveolar macrophages (AM), which are enhanced by GM-SCF, are an essential piece of the innate immune response and are known to contribute to host defense against flu infections in animal models.
by Staff Writers
Washington DC (SPX) Apr 27, 2011
New research on mice has shown that pulmonary administration of granulocyte macrophage-colony stimulating factor (GM-CSF) significantly reduces flu symptoms and prevents death after a lethal dose influenza virus. While GM-SCF therapy for humans as a flu prophylaxis or treatment may be years away, the study results were striking: All of the mice treated with GM-SCF survived after being infected with the influenza virus, whereas untreated mice all died from the same infection.

"Such unique and unambiguous results demonstrate the great potential of GM-CSF and may be the remedy for a critical public health priority: developing strategies to reduce the morbidity and mortality from influenza," said Homayoun Shams, PhD, principal investigator of the study.

The results were posted online ahead of the print edition of the American Journal of Respiratory and Critical Care Medicine.

Each year, flu infects 3 to 5 million people worldwide and is responsible for 250-500,000 deaths, according to the World Health Organization. Genetic mutations of influenza virus reduce the potency of flu vaccines, and a vaccinated person may contract flu, develop complications and even die due to poor host immune responses to vaccine or mutated virus strains.

Vaccinations work by activating the host's adaptive immunity in advance of infection. However, if the immune system is compromised, a vaccination may not provoke an adequate immune response to confer protection. Additionally, vaccine-induced immunity takes time to develop. If an individual is exposed shortly before or after being vaccinated, the vaccine will likely have little or no effect on his or her immunity.

"Improved methods to protect against influenza are sorely needed, particularly in the face of an impending pandemic. Development of such methods hinges on understanding host mechanisms that confer robust protection against influenza," said Dr. Shams.

"Despite the widespread use of vaccines, influenza causes significant morbidity and mortality throughout the world, and those with poor immune systems are particularly more susceptible-such as very young, elderly or immunocompromised individuals."

GM-SCF boosts innate immunity to make it immediately effective against the virus, and its protective effect has not been shown to be strain dependant so far. Alveolar macrophages (AM), which are enhanced by GM-SCF, are an essential piece of the innate immune response and are known to contribute to host defense against flu infections in animal models.

"Unlike a vaccine, GM-SCF does not rely heavily on the body's ability to mount an immune counter-attack against a specific antigen or virus strain, but enhances the speed of local responses to virus infection and delicately balances the host immune responses," explained Dr. Shams.

Dr. Shams and colleagues wanted to test the idea that boosting AM by introducing GM-SCF would protect against flu. They used three types of mice to test their hypothesis: wild-type (WT) mice, transgenic mice that do not express any GM-SCF (GM-/-), and transgenic mice that express GM-SCF only in the lung (SPC-GM). They infected all three strains of mice with lethal doses of influenza virus.

After progressive weight loss, all WT and GM-/- mice died within days. In contrast, all SPC-GM mice survived, and they gained back the weight they initially lost after a short period.

"This proves the concept that GM-SCF, only in the lung, is sufficient to provide complete protection against infection with otherwise lethal doses of influenza virus strains," said Dr. Shams.

"This finding delineates a novel means of conferring marked resistance to influenza through enhancing innate immune mechanisms that depend on AM. We found that SPC-GM mice that overexpress GM-SCF only in the lungs are highly resistant to infection with laboratory and clinical influenza strains, including the recent pandemic swine H1N1 strain."

GM-SCF is already in use in humans as a therapy for neutropenia, and Dr. Shams hopes to eventually test its effectiveness in clinical trials for preventing or treating flu exposure. "If additional work determines that delivery of GM-SCF to the lungs after onset of symptoms improves the outcome of influenza infection, this strategy has great potential to represent a new intervention to reduce morbidity and mortality from influenza in humans," he said.



Share This Article With Planet Earth
del.icio.usdel.icio.us DiggDigg RedditReddit
YahooMyWebYahooMyWeb GoogleGoogle FacebookFacebook



Related Links
American Thoracic Society
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola



Memory Foam Mattress Review
Newsletters :: SpaceDaily :: SpaceWar :: TerraDaily :: Energy Daily
XML Feeds :: Space News :: Earth News :: War News :: Solar Energy News


EPIDEMICS
At least 10 years to eradicate bird flu: UN health agency
Rome (AFP) April 21, 2011
It will take at least 10 years to eradicate the H5N1 bird flu virus, which has killed scores of humans, from poultry in the six countries where it is endemic, a UN agency said Thursday. The strain of the avian influenza virus was reported in 60 countries at its peak in 2006 but most had managed to stamp it out, the Food and Agriculture Organisation said in a report. It however remained " ... read more







EPIDEMICS
In tsunami-hit Japan, a mother finally finds closure

Japan imperial couple visit tsunami zone

Belarus leader fumes over Chernobyl anniversary

Higher radioactivity level at Bulgarian plant: operators

EPIDEMICS
Chernobyl's radioactivity reduced the populations of birds of orange plumage

Lake life around Chernobyl said thriving

Researchers Discover Optical Secrets of Metallic Beetles

Sony challenges iPad in tablet war

EPIDEMICS
VIMS study shows propeller turbulence may affect marine food webs

Japan mulls safety certificate for seafood: report

Turkey to build water channel to bypass Bosphorus: PM

Conservation of coastal dunes is threatened by poorly designed infrastructure

EPIDEMICS
Calling all candidates for Concordia

Melting ice on Arctic islands a major player in sea level rise

ESA-NASA Collaboration Furthers Sea-Ice Research

Melting ice on Arctic islands boosts sea levels: study

EPIDEMICS
Rural development gets help from the sky

Stressed out crop impede higher agriculture yields

Rising food costs could fuel Asian poverty

Can biochar help suppress greenhouse gases

EPIDEMICS
Forecasters predict multiple US hurricane landfalls

Ecuador on alert after volcano erupts

Rain is Colombia's 'worst' natural disaster: Santos

'Right' to shut down air space over Iceland volcano: study

EPIDEMICS
Nigeria holds final polls despite violence

Burkina Faso president assumes defence post

Work on Sudan split continues

Chinese aid good for Africa: ministers

EPIDEMICS
Evolution of human 'super-brain' tied to development of bipedalism, tool-making

Berlusconi, Sarkozy meet over migrants

Pope urges 'solidarity' with refugees from conflict

Walker's World: Europe's frontiers close


The content herein, unless otherwise known to be public domain, are Copyright 1995-2010 - SpaceDaily. AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement